A total of 120 Chinese patients with AICAS were enrolled and randomly divided into three groups [ low-dose atorvastatin therapy ( LAT , 10mg/day ) , standard-dose atorvastatin therapy ( SAT , 20mg/day ) , and intensive-dose atorvastatin therapy ( IAT , 40mg/day ) groups ] in a 1:1:1 ratio .